PLUR

Pluri Inc

• TipRanks·03/27 12:47

  Pluri Announces Financing Through Unregistered Equity Securities Deal

• TipRanks·03/26 12:46

  Pluri announces additional $2.5M investment from Alejandro Weinstein

• Benzinga·03/26 12:39

  Pluri Signs Agreement With Beneficiary Owned By Chairman Alejandro Weinstein For Additional $2.5M Investment In Co.

• TipRanks·03/02 14:28

  Pluri Regains Nasdaq Compliance, Restoring Listing Stability

• TipRanks·02/18 13:26

  Pluri secures global IP position with CNIPA for immune cell expansion

• Benzinga·02/18 13:03

  Pluri Subsidiary Puri Biotech Secures Patent Covering 3D Immune Cell Expansion Tech

• Benzinga·02/12 22:21

  Pluri Q2 EPS $(0.71) Misses $(0.65) Estimate, Sales $198.000K Miss $638.000K Estimate

• TipRanks·01/22 21:37

  Pluri Faces Nasdaq Noncompliance Notice, Evaluating Listing Options

• TipRanks·01/22 14:20

  Pluri completes first phase of program with Resbiomed Technologies OOD

• Benzinga·01/22 14:18

  Pluri Completes First Phase Of Its Program With Resbiomed Technologies OOD Over Placenta-Derived Processing, Bioprocessing Capabilities

• TipRanks·12/22/2025 12:10

  Pluri announces expansion of manufacturing agreement with Remedy Cell

• Benzinga·12/22/2025 12:08

  Pluri Expands Manufacturing Agreement With Remedy Cell, Advances Clinical-Grade Production

• Benzinga·12/22/2025 12:05

  12 Health Care Stocks Moving In Monday's Pre-Market Session

• Benzinga·12/18/2025 17:06

  12 Health Care Stocks Moving In Thursday's Intraday Session

• TipRanks·12/09/2025 21:38

  Pluri Grants RSUs to Executives and Board Members